Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Disease Registry Encompassing the Care of Patients With Multiple Myeloma on Panobinostat (RECOMM)

NCT04150289 is registered in ClinicalTrials.gov with pharmaand GmbH as lead sponsor.

NCT NCT04150289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04150289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Disease Registry Encompassing the Care of Patients With Multiple Myeloma on Panobinostat (RECOMM)
Lead sponsor
pharmaand GmbH
Phase
Observational
Overall status
Completed
Start date
November 4, 2019
Completion date
March 30, 2022
Enrollment
248 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma